<DOC>
	<DOCNO>NCT00003287</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know regimen combination chemotherapy effective treating patient recurrent metastatic colorectal cancer . PURPOSE : Randomized phase III trial study effectiveness combine fluorouracil , leucovorin , oxaliplatin different way treat patient recurrent metastatic colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Recurrent Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect chronomodulated versus nonchronomodulated infusional administration 3 drug high-dose chemotherapy regimen survival patient locoregionally recurrent metastatic colorectal cancer . II . Assess antitumor effect combination fluorouracil , leucovorin calcium , oxaliplatin give first line chemotherapy patient . III . Assess response rate toxicity treatment patient . IV . Assess quality life patient receive treatment . OUTLINE : This randomize , multicenter study . Patients stratify accord performance status ( ECOG 0-1 v 2 ) , extent liver involvement ( none v le 25 % vs 25 % great ) , institution . Patients randomize 2 arm : Arm I ( chronotherapy ) : Patients receive 4 day infusion fluorouracil , leucovorin calcium , oxaliplatin administer via pump use chronomodulated delivery rate . Arm II ( fix infusion rate ) : Patients receive leucovorin calcium oxaliplatin 2 hour concurrent infusion follow fluorouracil 22 hour infusion day 1 . On day 2 , patient receive 2 hour infusion leucovorin calcium follow 22 hour infusion fluorouracil . For patient arm , course repeat every 2 week occurrence disease progression , severe toxicity , complete remission minimum 4 month . Quality life assess prior treatment 2 week course 4 8 . Patients follow survival . PROJECTED ACCRUAL : A total 554 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove locoregionally recurrent metastatic adenocarcinoma colon rectum Histologic cytologic proof adenocarcinoma consistent colorectal cancer solitary lesion plasma carcinoembryonic antigen level great normal Metastases limit bone , pleural effusion , ascites Surgically resectable metastasis eligible No symptomatic brain metastasis At least one bidimensionally measurable lesion measure least 20 mm one diameter outside previously irradiate area PATIENT CHARACTERISTICS : Age : 18 75 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 3 time upper limit normal Renal : No uncontrolled hypercalcemia Cardiovascular : No significant cardiac disease Pulmonary : No severe respiratory illness Neurologic : No peripheral sensory neuropathy Other : No uncontrolled infection chronic disease No second malignancy except basal cell carcinoma skin situ carcinoma cervix PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy locoregionally recurrent metastatic colorectal cancer No concurrent prophylactic growth factor Chemotherapy : No prior chemotherapy locoregionally recurrent metastatic colorectal cancer At least 6 month since adjuvant chemotherapy Endocrine therapy : No prior hormone therapy locoregionally recurrent metastatic colorectal cancer No concurrent corticosteroid Radiotherapy : See Disease Characteristics No prior radiotherapy locoregionally recurrent metastatic colorectal cancer Concurrent localize analgesic radiotherapy bone lesion permit unless indicative disease progression Surgery : No prior surgery locoregionally recurrent metastatic colorectal cancer Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>